eXludus Technologies, whose software dramatically boosts application throughput for compute clusters and Grids, today announced that it has joined the BioIT Alliance, a cross-industry group working to integrate science and technology in order to accelerate the pace of drug discovery and realize the potential of personalized medicine. "eXludus will contribute leadership in accelerating time-to-discovery through more efficient processing of biomedical applications and data across clusters and Grids, which are today's mainstream computing environments," said Dr. Stephen Perrenod, eXludus's vice president of worldwide sales and marketing. "We are excited about collaborating with the other leading solution providers who are members of the BioIT Alliance." Rudy Potenzone , BioIT Alliance Manager and Industry Technology Strategist for Pharmaceuticals, said, "We welcome eXludus and their expertise to the best-in-class companies that make up the BioIT Alliance. The company's Grid Optimizer software can substantially increase throughput in clusters and Grids running workloads with tens, hundreds or thousands of concurrent user jobs. Faster throughput directly contributes to the BioIT Alliance's goal of accelerating scientific discovery." eXludus Technologies was singled out in Bio-IT World's list of the top 10 Bio-IT trends for 2007, authored by the BioTeam. For more information, go to its Web site.